Abstract 4368581: Relationship Between Unilateral Antegrade Cerebral Perfusion, Peripheral Immune Hyper-Reactivity and Cognition in a Translational Model of Hypothermic Circulatory Arrest

H Hawley Helmbrecht (Johns Hopkins University, Baltimore, Maryland, United States) J Jessica Briscoe (Johns Hopkins University, Baltimore, Maryland, United States) T Timothy Heck (Johns Hopkins University, Baltimore, Maryland, United States) A AlleaBelle Bradshaw (Johns Hopkins University School of Medicine, Baltimore, Maryland, United States) R Riddhi Patel B Balaji Vijayakumar (Johns Hopkins University, Baltimore, Maryland, United States) R Rachael Quinn H Hilkiah Suga (Johns Hopkins University, Baltimore, Maryland, United States) N Nivedita Kumar (Johns Hopkins Medicine, Baltimore, Maryland, United States) S Shivani Shirodkar J Jie Wang (State Key Laboratory of Molecular Oncology, Beijing Key Laboratory, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology Cancer Hospital, Chinese Academy of Medical Sciences Beijing China) A Annie Butt (Johns Hopkins University, Baltimore, Maryland, United States) B Bruno Henrique Dallo Gallo (Johns Hopkins University, Baltimore, Maryland, United States) R Regina Fernandez H Hee Cheol Cho L Lee Martin J Joseph Scafidi S Shenandoah Robinson (Johns Hopkins University, Baltimore, Maryland, United States) J Jennifer Lawton (Johns Hopkins University, Baltimore, Maryland, United States) L Lauren Jantzie (Johns Hopkins University, Baltimore, Maryland, United States)

Abstract

Introduction: Hypothermic circulatory arrest (HCA) is associated with neurological damage. During HCA, antegrade cerebral perfusion (ACP) supports neuroprotection by perfusing the brain with oxygenated blood. Optimal ACP flow rates aim to maintain near-physiological conditions and provide neuroprotection by preventing ischemia and subsequent immune activation, therefore improving cognition and memory. Hypothesis: We hypothesized that an ideal neuroprotective ACP flow rate exists that impacts immune activation and function, resulting in altered levels of peripheral inflammatory proteins, immune reactivity, and cognition. Methods: Animals and Surgery: Eighteen canines were randomized into three groups with different ACP flow rates 2.5, 5, and 10 mL/kg/min. Canines were anesthetized, cannulated for peripheral cardiopulmonary bypass, and cooled to 18 °C. Cognition was assessed using Novel Object Recognition. Peripheral Blood Mononuclear Cell Isolation, Culture, and Challenge: At 48 hours post-operation, blood was collected and serum separated. PBMCs were isolated and cultured; some cells were challenged with lipopolysaccharide (LPS). After 4 and 24hrs of culture, the cells and media were collected. Inflammatory markers were evaluated with ELISA. Results: 24h following HCA, no experimental group demonstrated preference for novelty. 48 hours post-op, canines in the 10 mL/kg/min ACP group had intact and improved cognition and the lowest levels of immune activation and inflammatory biomarkers. Canines receiving 10mL/Kg/min demonstrated preference for the novel objects and nearly doubled interaction time (p<0.05). This improvement in cognition was concomitant with the lowest levels of IL-6, IL-8, TNFa, and MCP-1/CCL2 in the PBMC secretome. Indeed, for PBMC reactivity, flow rate and inflammatory drive were inversely related, with the 2.5 mL/kg/min group secreting the highest levels of IL-6, IL-8, TNFa, and MCP-1/CCL2 at baseline. After the challenge with a secondary inflammatory stimulus in culture (LPS), PBMCs isolated from the 5mL/kg/min group expressed the highest levels of each inflammatory marker, with the lowest response in the 10 mL/kg/min group. Conclusion: Our findings support the incorporation of ACP during cardiac surgery as a reliable neuroprotection strategy in patients undergoing HCA. 10 mL/kg/min ACP flow rate showed evidence of neuroprotection with improved object recognition alongside decreased inflammatory response and reactivity.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (20)

H

Hawley Helmbrecht

Johns Hopkins University, Baltimore, Maryland, United States

J

Jessica Briscoe

Johns Hopkins University, Baltimore, Maryland, United States

T

Timothy Heck

Johns Hopkins University, Baltimore, Maryland, United States

A

AlleaBelle Bradshaw

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

R

Riddhi Patel

B

Balaji Vijayakumar

Johns Hopkins University, Baltimore, Maryland, United States

R

Rachael Quinn

H

Hilkiah Suga

Johns Hopkins University, Baltimore, Maryland, United States

N

Nivedita Kumar

Johns Hopkins Medicine, Baltimore, Maryland, United States

S

Shivani Shirodkar

J

Jie Wang

State Key Laboratory of Molecular Oncology, Beijing Key Laboratory, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology Cancer Hospital, Chinese Academy of Medical Sciences Beijing China

A

Annie Butt

Johns Hopkins University, Baltimore, Maryland, United States

B

Bruno Henrique Dallo Gallo

Johns Hopkins University, Baltimore, Maryland, United States

R

Regina Fernandez

H

Hee Cheol Cho

L

Lee Martin

J

Joseph Scafidi

S

Shenandoah Robinson

Johns Hopkins University, Baltimore, Maryland, United States

J

Jennifer Lawton

Johns Hopkins University, Baltimore, Maryland, United States

L

Lauren Jantzie

Johns Hopkins University, Baltimore, Maryland, United States